Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...

Health care leaders and professionals constantly seek ways to improve their clients’ lifestyles. In recent times, nutritional programs have emerged as a tool that provides a balanced diet to drive ...

If you’ve ever Googled “best weight loss program,” you know the options are endless—and overwhelming. From meal delivery to macro tracking, it can be hard to know which approach actually works, and ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

Millions of patients taking GLP-1 receptor agonists such as semaglutide have achieved dramatic weight loss, but a growing ...

Market opportunities lie in the expansion of medical weight loss programs, rising demand for GLP-1 drugs, and increased roles for physicians and bariatricians in weight management. With declining ...

Noom Med is a medically-guided weight loss program that combines clinical care with Noom's behavior-change tools. The program provides virtual consultations, medication management, and nutrition ...